Talking Rheumatology Research

Aug 25 2024 47 ep. 12 mins 14
Talking Rheumatology Research Podcast artwork

Discover the latest research from Rheumatology, Rheumatology Advances in Practice, and beyond.

  Health & Fitness
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis

Aug 25 2024 10 mins  
Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients. Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care and treatment for GCA patients, including increasing disease awareness, faster referral to specialised care, better access to diagnostic tools, and a mu

Ep 46. Patient involvement in Rheumatology research

Jul 10 2024 21 mins  
Peter Boyd and Ingrid de Groot join Dr. Latika Gupta to explore the value of patient involvement in Rheumatology research. Reflecting on their lived experience, Peter and Ingrid discuss their proudest moments, and identify areas in the patient and physician partnership that they hope to improve in the future.Thanks for listening to Talking Rheumatology Research! Join the conversati

Ep 45. Community awareness of childhood arthritis in the UK

Jun 12 2024 9 mins  
Recorded at #BSR24, Richard P Beesley joins Dr Ai Lyn Tan to discuss his recent article, which measured the level of community awareness in the UK that children and young people can develop arthritis.Listen now to hear about what you can do to help raise awareness of childhood arthritis, and why this is so important.You can read this article [https://doi.org/10.1093/rap/rkad099] in

Ep 44. Neuropsychiatric symptoms in systemic autoimmune rheumatic diseases

May 23 2024 12 mins  
In this fascinating episode recorded at #BSR24, Dr Melanie Sloan joins Prof Ernest Choy to discuss the latest results from the INSPIRE study, which seeks to understand neuropsychiatric symptom prevalence and impact in people with systemic autoimmune rheumatic diseases (SARDs). Dr Melanie Sloan is a researcher in the Department of Public Health and Primary Care at the University of

Ep. 43 The metaverse: a new frontier for rheumatology

Apr 10 2024 11 mins  
Dr Jason E Liebowitz joins Dr Marwan Bukhari to discuss the metaverse and how the field of rheumatology can utilise virtual and augmented reality to improve the lives of patients.Listen now to hear about the current technological developments and what this means for future clinical practice! You can read this article [https://doi.org/10.1093/rheumatology/kead534] in Rheumatology.Th

Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?

Jan 10 2024 17 mins  
Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab.Listen now to hear the findings and what this means for future clinical practice! You can read this arti

Ep 41. Addressing the leaky pipeline

Jan 03 2024 17 mins  
What is the leaky pipeline and how do we address it? Prof Christina Duftner (University of Innsbruck) and Prof Isabella Grabner (Vienna University of Economics and Business) join Dr Latika Gupta to discuss the diminishing proportion of women in higher ranking and leadership roles within rheumatology. Want to read more? Here's your further reading list:1. Read Christina and Isabella

Ep 40. New Editor-in-Chief: Introducing Prof Ernest Choy

Dec 20 2023 4 mins  
We're delighted to announce Prof Ernest Choy (University of Cardiff) as the incoming Editor-in-Chief of Rheumatology. In this episode, recorded at ACR23, Ernest tells us about his plans for the journal and the type of research he's keen to see. Ernest will take the reins from Dr Marwan Bukhari (Royal Lancaster Infirmary), who finishes his highly productive term as Editor-in-Chief i

Ep 39. UK JIA Biologics Register: stopping biologics for remission

Nov 29 2023 10 mins  
What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register. Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a consultant rheumatologist based at

Ep 38. Is risankizumab safe and effective for active psoriatic arthritis? Results from the KEEPsAKE 2 study

Oct 25 2023 7 mins  
Dr Andrew Östör joins Dr Marwan Bukhari to discuss their article, chosen as the June Editor's Choice article, which evaluates the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate response/intolerance to one or two biologic therapies (Bio-IR) or one or more conventional synthetic DMARDs (csDMARD-IR).Listen now to hear the f